Kazia Therapeutics Limited. Key Management Personnel Compensation
Kazia Therapeutics Limited. (KZIA) reported Key Management Personnel Compensation of AUD 2.14 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2025-11-07
| Period end | Key Management Personnel Compensation 12 month | Key Management Personnel Compensation 12 month as first filed |
|---|---|---|
| 2025-06-30 | 2.14M AUD 20-F · filed 2025-11-07 | |
| 2024-06-30 | 2.39M AUD 20-F · filed 2025-11-07 | |
| 2023-06-30 | 4.34M AUD 20-F · filed 2025-11-07 | |
| 2022-06-30 | 4.26M AUD 20-F · filed 2024-11-15 | 4.26M AUD 20-F · filed 2022-10-17 |
| 2021-06-30 | 2.30M AUD 20-F · filed 2023-10-26 | |
| 2020-06-30 | 1.65M AUD 20-F · filed 2022-10-17 | |
| 2019-06-30 | 1.39M AUD 20-F · filed 2021-10-07 | |
| 2018-06-30 | 1.84M AUD 20-F · filed 2020-10-22 | |
| 2017-06-30 | 3.39M AUD 20-F · filed 2019-10-21 | |
| 2016-06-30 | 2.10M AUD 20-F · filed 2018-10-24 |